Male contraceptive Adjudin is a potential anti-cancer drug

Biochemical Pharmacology

Volumn 85, Issue 3, 2013, Pages 345-355

  Xie, Qian Reuben ^a   Liu, Yewei ^a   Shao, Jiaxiang ^a   Yang, Jian ^a   Liu, Tengyuan ^a   Zhang, Tingting ^a   Wang, Boshi ^a   Mruk, Dolores D ^c   Silvestrini, Bruno ^d   Cheng, C Yan ^c   Xia, Weiliang ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c POPULATION COUNCIL   (United States)

^d Medical Chemistry Laboratory   (Italy)

Author keywords

Adjudin; Anti cancer; Mitochondrial dysfunction

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADJUDIN; AF 2364; ANTINEOPLASTIC AGENT; CASPASE 3; CISPLATIN; LONIDAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; INOCULATION; LUNG CANCER; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; CONTRACEPTIVE AGENTS, MALE; HUMANS; HYDRAZINES; INDAZOLES; MALE; MICE; MICE, NUDE; MOLECULAR STRUCTURE; NEOPLASMS, EXPERIMENTAL;

EID: 84872674745     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.11.008     Document Type: Article

References (37)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA: Cancer J Clin 61 2011 69 90
2. M. Dougan, and G. Dranoff Immune therapy for cancer Annu Rev Immunol 27 2009 83 117
3. R.W. Johnstone, A.A. Ruefli, and S.W. Lowe Apoptosis: a link between cancer genetics and chemotherapy Cell 108 2002 153 164
4. I. Ben Sahra, Y. Le Marchand-Brustel, J.F. Tanti, and F. Bost Metformin in cancer therapy: a new perspective for an old antidiabetic drug Mol Cancer Therapeut 9 2010 1092 1099
5. Y. Geng, L. Kohli, B.J. Klocke, and K.A. Roth Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent Neuro-oncol 12 2010 473 481
6. A. Munshi Chloroquine in glioblastoma - new horizons for an old drug Cancer 115 2009 2380 2383
7. C.Y. Cheng, D. Mruk, B. Silvestrini, M. Bonanomi, C.H. Wong, and M.K. Siu AF-2364 [1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide] is a potential male contraceptive: a review of recent data Contraception 72 2005 251 261
8. C.Y. Cheng, B. Silvestrini, J. Grima, M.Y. Mo, L.J. Zhu, and E. Johansson Two new male contraceptives exert their effects by depleting germ cells prematurely from the testis Biol Reprod 65 2001 449 461
9. D.D. Mruk, C.H. Wong, B. Silvestrini, and C.Y. Cheng A male contraceptive targeting germ cell adhesion Nat Med 12 2006 1323 1328
10. W. Xia, E.W. Wong, D.D. Mruk, and C.Y. Cheng TGF-beta3 and TNFalpha perturb blood-testis barrier (BTB) dynamics by accelerating the clathrin-mediated endocytosis of integral membrane proteins: a new concept of BTB regulation during spermatogenesis Dev Biol 327 2009 48 61
11. W. Xia, D.D. Mruk, and C.Y. Cheng C-type natriuretic peptide regulates blood-testis barrier dynamics in adult rat testes Proc Natl Acad Sci USA 104 2007 3841 3846
12. B. Silvestrini, G. Palazzo, and M. De Gregorio Lonidamine and related compounds Prog Med Chem 21 1984 110 135
13. S. Di Cosimo, G. Ferretti, P. Papaldo, P. Carlini, A. Fabi, and F. Cognetti Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors Drugs Today (Barc) 39 2003 157 174
14. L. Ravagnan, I. Marzo, P. Costantini, S.A. Susin, N. Zamzami, and P.X. Petit Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore Oncogene 18 1999 2537 2546
15. O. Sordet, C. Rebe, I. Leroy, J.M. Bruey, C. Garrido, and C. Miguet Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis Blood 97 2001 3931 3940
16. S. Oudard, A. Carpentier, E. Banu, F. Fauchon, D. Celerier, and M.F. Poupon Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme J Neurooncol 63 2003 81 86
17. E. Miller-Kasprzak, and P.P. Jagodzinski Endothelial progenitor cells as a new agent contributing to vascular repair Arch Immunol Ther Exp (Warsz) 55 2007 247 259
18. X. Li, Q.R. Xie, J. Zhang, W. Xia, and H. Gu The packaging of siRNA within the mesoporous structure of silica nanoparticles Biomaterials 32 2011 9546 9556
19. R.K. Dagda, S.J. Cherra 3rd, S.M. Kulich, A. Tandon, D. Park, and C.T. Chu Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission J Biol Chem 284 2009 13843 13855
20. L. Su, C.Y. Cheng, and D.D. Mruk Adjudin-mediated Sertoli-germ cell junction disassembly affects Sertoli cell barrier function in vitro and in vivo Int J Biochem Cell Biol 42 2010 1864 1875
21. I.M. Ghobrial, T.E. Witzig, and A.A. Adjei Targeting apoptosis pathways in cancer therapy CA: Cancer J Clin 55 2005 178 194
22. K.F. Ferri, and G. Kroemer Control of apoptotic DNA degradation Nat Cell Biol 2 2000 E63 E64
23. M. Marella, B.B. Seo, A. Matsuno-Yagi, and T. Yagi Mechanism of cell death caused by complex I defects in a rat dopaminergic cell line J Biol Chem 282 2007 24146 24156
24. E. Calvino, M.C. Estan, G.P. Simon, P. Sancho, C. Boyano-Adanez Mdel, and E. de Blas Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation Biochem Pharmacol 82 2011 1619 1629
25. Y.C. Li, K.P. Fung, T.T. Kwok, C.Y. Lee, Y.K. Suen, and S.K. Kong Mitochondrial targeting drug lonidamine triggered apoptosis in doxorubicin-resistant HepG2 cells Life Sci 71 2002 2729 2740
26. A.S. Belzacq, C. El Hamel, H.L. Vieira, I. Cohen, D. Haouzi, and D. Metivier Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437 Oncogene 20 2001 7579 7587
27. D.C. Chan Mitochondria: dynamic organelles in disease, aging, and development Cell 125 2006 1241 1252
28. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
29. L.M. DeAngelis, V.E. Currie, J.H. Kim, G. Krol, M.A. O'Hehir, and F.M. Farag The combined use of radiation therapy and lonidamine in the treatment of brain metastases J Neurooncol 7 1989 241 247
30. B. Silvestrini, G.M. Hahn, V. Cioli, and C. De Martino Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems Br J Cancer 47 1983 221 231
31. H. Wang, X.X. Chen, L.R. Wang, Y.D. Mao, Z.M. Zhou, and J.H. Sha AF-2364 is a prospective spermicide candidate Asian J Androl 12 2010 322 335
32. B.I. Rini, S. Halabi, J.E. Rosenberg, W.M. Stadler, D.A. Vaena, and L. Archer Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206 J Clin Oncol 28 2010 2137 2143
33. P. Papaldo, M. Lopez, E. Cortesi, E. Cammilluzzi, M. Antimi, and E. Terzoli Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide J Clin Oncol 21 2003 3462 3468
34. K.W. Mok, D.D. Mruk, P.P. Lie, W.Y. Lui, and Cheng C.Y. Adjudin a potential male contraceptive, exerts its effects locally in the seminiferous epithelium of mammalian testes Reproduction 141 2011 571 580
35. K.W. Mok, D.D. Mruk, W.M. Lee, and C.Y. Cheng A study to assess the assembly of a functional blood-testis barrier in developing rat testes Spermatogenesis 1 2011 270 280
36. E. Naumova, P. Ubezio, A. Garofalo, P. Borsotti, L. Cassis, and E. Riccardi The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis Clin Cancer Res 12 2006 1839 1849
37. Q. Liu, J. Zhang, W. Sun, Q.R. Xie, W. Xia, and H. Gu Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells Int J Nanomed 7 2012 999 1013